Log in or Sign up for Free to view tailored content for your specialty!
Neurocritical Care News
Rules on contact, equipment, testing can address concussions in ice hockey
Concussions suffered in hockey led to substantial missed playing time, while their physical effects require leagues of all ages to bolster rules, utilize protective equipment and implement high-quality injury protocols to address the issue.
Gender may not impact high school athlete return to learn after sport-related concussion
Published results showed gender may not be a significant factor in return to learn rates for high school athletes with sports-related concussions.
Log in or Sign up for Free to view tailored content for your specialty!
Q&A: ‘Exciting time’ for research into, development of treatments for CIDP
Although there are no current reliable tests and few treatments for chronic inflammatory demyelinating polyneuropathy, which affects about 40,000 individuals in the U.S., recent FDA approvals have made treatments a possibility.
Head, neck cooling device may reduce concussion symptoms in adolescent athletes
Published results showed an investigational head and neck cooling device reduced symptom severity for adolescent athletes with a sports-related concussion compared with standard post-concussion care alone.
PrimeC led to significant slowing in rate of decline in ALS at 12 months
NeuroSense Therapeutics Ltd. has reported positive results from the 12-month data analysis of a phase 2b study evaluating a novel extended-release oral formulation combination therapy in patients with amyotrophic lateral sclerosis.
Physical exercise prevents nerve damage caused by chemotherapy
Certain physical exercises may prevent nerve damage caused by chemotherapy among individuals being treated for cancer, results of a randomized study published in JAMA Internal Medicine showed.
Tissue bridges linked with short, long-term benefits in those with spinal cord injury
Implementation of tissue bridges measured within the first weeks after spinal cord injury are linked with short-and-long-term clinical improvement, according to research from The Lancet Neurology.
Monoclonal antibody for FSHD improves muscle strength with no serious adverse events
Avidity Biosciences Inc. has announced positive data from the phase 1/2 FORTITUDE clinical trial of a proprietary monoclonal antibody that binds to the transferrin receptor 1 conjugated with a siRNA targeting DUX4 mRNA.
VIDEO: Antibiotics linked to exacerbation of myasthenia gravis
DENVER — The use of several common antibiotics led to exacerbation of myasthenia gravis in a small cohort of patients, Sanem P. Uysal, MD, said in this Healio video from the American Academy of Neurology annual meeting.
Results positive in study of antisense oligonucleotide for Huntington’s disease
Wave Life Sciences has announced positive results from its phase 1b/2a clinical trial of WVE-003, a potential disease-modifying therapeutic for Huntington’s disease.
-
Headline News
A potential new paradigm for treating acute migraine: Timolol nasal spray
November 15, 20245 min read -
Headline News
AI-enabled video of skin on face, hands may detect high blood pressure, diabetes
November 15, 20242 min read -
Headline News
‘Troubling’ data show lack of awareness about lung cancer screening
November 15, 20242 min read
-
Headline News
A potential new paradigm for treating acute migraine: Timolol nasal spray
November 15, 20245 min read -
Headline News
AI-enabled video of skin on face, hands may detect high blood pressure, diabetes
November 15, 20242 min read -
Headline News
‘Troubling’ data show lack of awareness about lung cancer screening
November 15, 20242 min read